{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:20Z","timestamp":1791860780571,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00296","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:18:48Z","timestamp":1525997928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Altered Serum Tumor Necrosis Factor and Interleukin-1\u03b2 in First-Episode Drug-Naive and Chronic Schizophrenia"],"prefix":"10.3389","volume":"12","author":[{"given":"Furong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.yhbeh.2012.02.012","article-title":"The effects of the stress response on immune function in invertebrates: an evolutionary perspective on an ancient connection","volume":"62","author":"Adamo","year":"2012","journal-title":"Horm. Behav."},{"key":"B2","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/011542650802300135","article-title":"Neurodegeneration and inflammation","volume":"23","author":"DeLegge","year":"2008","journal-title":"Nutr. Clin. Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.schres.2015.11.006","article-title":"Relationship of serum levels of TNF-\u03b1, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers","volume":"169","author":"Fan","year":"2015","journal-title":"Schizophr. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1586\/14737175.7.7.789","article-title":"Inflammation and schizophrenia","volume":"7","author":"Fan","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psychres.2011.05.010","article-title":"C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia","volume":"190","author":"Fawzi","year":"2011","journal-title":"Psychiatry Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1\u03b2 in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.schres.2016.05.010","article-title":"Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia","volume":"176","author":"Fu","year":"2016","journal-title":"Schizophr. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/sj.npp.1300217","article-title":"Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype","volume":"28","author":"Garver","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s002139900351","article-title":"Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight","volume":"149","author":"Hinze-Selch","year":"2000","journal-title":"Psychopharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2008.10.024","article-title":"Tyrosine hydroxylase, interleukin-1\u03b2 and tumor necrosis factor-\u03b1 are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis","volume":"176","author":"Liu","year":"2010","journal-title":"Psychiatry Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ajmg.b.30405","article-title":"Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment","author":"Mata","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","article-title":"The immune system and schizophrenia. An integrative view","volume":"917","author":"M\u00fcller","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.11.023","article-title":"Cytokines dysregulation in schizophrenia: a systematic review of psychoneuroimmune relationship","author":"Rodrigues-Amorim","year":"2017","journal-title":"Schizophr. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.devbrainres.2005.06.009","article-title":"Angiotensin, I. I., and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors","volume":"158","author":"Rodriguez-Pallares","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s12035-016-9791-8","article-title":"Early loss of blood-brain barrier integrity precedes NOX2 elevation in the prefrontal cortex of an animal model of psychosis","volume":"54","author":"Schiavone","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fpsyt.2017.00203","article-title":"Inflammation, stress response, and redox dysregulation biomarkers: clinical outcomes and pharmacological implications for psychosis","volume":"8","author":"Schiavone","year":"2017","journal-title":"Front. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/mp.2009.52","article-title":"Activation of brain interleukin-1\u03b2 in schizophrenia","volume":"14","author":"S\u00f6derlund","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"key":"B29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","article-title":"The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia","volume":"65","author":"Song","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","article-title":"Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha","volume":"96","author":"Sriram","year":"2006","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7499\/j.issn.1008-8830.2014.01.014","article-title":"Methylenetetrahydrofolate reductase deficiency-induced schizophrenia in a school-age boy","volume":"16","author":"Wang","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2014.03.024","article-title":"Decreased interleukin-10 serum levels in first-episode drug-naive schizophrenia: relationship to psychopathology","volume":"156","author":"Xiu","year":"2014","journal-title":"Schizophr. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00213-008-1295-4","article-title":"Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics","volume":"201","author":"Zhang","year":"2008","journal-title":"Psychopharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbi.2014.01.017","article-title":"Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: Implication for a new schizophrenia animal model","volume":"38","author":"Zhu","year":"","journal-title":"Brain Behav. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e93966","DOI":"10.1371\/journal.pone.0093966","article-title":"Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats","volume":"9","author":"Zhu","year":"","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3760\/cma.j.issn.0376-2491.2015.47.005","article-title":"Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients","volume":"95","author":"Zhu","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:18:53Z","timestamp":1525997933000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":39,"alternative-id":["10.3389\/fnins.2018.00296"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00296","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"article-number":"296"}}